[1]
2018. IPILIMUMAB IN PATIENTS WITH DISSEMINATED MELANOMA: THE N.N. PETROV NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY EXPANDED ACCESS PROGRAM EXPERIENCE. Voprosy onkologii. 64, 3 (Mar. 2018), 388–393. DOI:https://doi.org/10.37469/0507-3758-2018-64-3-388-393.